nodes	percent_of_prediction	percent_of_DWPC	metapath
Nedocromil—HSP90AA1—endothelium—acquired immunodeficiency syndrome	0.0126	0.0454	CbGeAlD
Nedocromil—FPR1—lymphoid tissue—acquired immunodeficiency syndrome	0.012	0.0433	CbGeAlD
Nedocromil—FPR1—digestive system—acquired immunodeficiency syndrome	0.0118	0.0427	CbGeAlD
Nedocromil—FPR1—blood—acquired immunodeficiency syndrome	0.0113	0.0407	CbGeAlD
Nedocromil—PTGDR—digestive system—acquired immunodeficiency syndrome	0.0112	0.0404	CbGeAlD
Nedocromil—HSP90AA1—blood plasma—acquired immunodeficiency syndrome	0.0112	0.0403	CbGeAlD
Nedocromil—CYSLTR2—lung—acquired immunodeficiency syndrome	0.011	0.0396	CbGeAlD
Nedocromil—FPR1—bone marrow—acquired immunodeficiency syndrome	0.0109	0.0394	CbGeAlD
Nedocromil—PTGDR—blood—acquired immunodeficiency syndrome	0.0106	0.0385	CbGeAlD
Nedocromil—PTGDR—bone marrow—acquired immunodeficiency syndrome	0.0103	0.0372	CbGeAlD
Nedocromil—FPR1—lung—acquired immunodeficiency syndrome	0.00988	0.0357	CbGeAlD
Nedocromil—PTGDR—vagina—acquired immunodeficiency syndrome	0.00986	0.0356	CbGeAlD
Nedocromil—PTGDR—lung—acquired immunodeficiency syndrome	0.00933	0.0337	CbGeAlD
Nedocromil—FPR1—nervous system—acquired immunodeficiency syndrome	0.00915	0.0331	CbGeAlD
Nedocromil—FPR1—central nervous system—acquired immunodeficiency syndrome	0.00881	0.0318	CbGeAlD
Nedocromil—HSP90AA1—Gemcitabine—Lamivudine—acquired immunodeficiency syndrome	0.00875	1	CbGdCrCtD
Nedocromil—PTGDR—nervous system—acquired immunodeficiency syndrome	0.00864	0.0312	CbGeAlD
Nedocromil—PTGDR—central nervous system—acquired immunodeficiency syndrome	0.00832	0.0301	CbGeAlD
Nedocromil—PTGDR—brain—acquired immunodeficiency syndrome	0.0066	0.0239	CbGeAlD
Nedocromil—PTGDR—lymph node—acquired immunodeficiency syndrome	0.00638	0.0231	CbGeAlD
Nedocromil—HSP90AA1—retina—acquired immunodeficiency syndrome	0.00611	0.0221	CbGeAlD
Nedocromil—HSP90AA1—skin of body—acquired immunodeficiency syndrome	0.00536	0.0194	CbGeAlD
Nedocromil—CYSLTR1—lymphoid tissue—acquired immunodeficiency syndrome	0.00501	0.0181	CbGeAlD
Nedocromil—CYSLTR1—blood—acquired immunodeficiency syndrome	0.00471	0.017	CbGeAlD
Nedocromil—CYSLTR1—bone marrow—acquired immunodeficiency syndrome	0.00456	0.0165	CbGeAlD
Nedocromil—CYSLTR1—vagina—acquired immunodeficiency syndrome	0.00437	0.0158	CbGeAlD
Nedocromil—HSP90AA1—lymphoid tissue—acquired immunodeficiency syndrome	0.00434	0.0157	CbGeAlD
Nedocromil—HSP90AA1—digestive system—acquired immunodeficiency syndrome	0.00429	0.0155	CbGeAlD
Nedocromil—CYSLTR1—lung—acquired immunodeficiency syndrome	0.00413	0.0149	CbGeAlD
Nedocromil—HSP90AA1—blood—acquired immunodeficiency syndrome	0.00409	0.0148	CbGeAlD
Nedocromil—HSP90AA1—bone marrow—acquired immunodeficiency syndrome	0.00395	0.0143	CbGeAlD
Nedocromil—HSP90AA1—spinal cord—acquired immunodeficiency syndrome	0.00394	0.0142	CbGeAlD
Nedocromil—CYSLTR1—nervous system—acquired immunodeficiency syndrome	0.00382	0.0138	CbGeAlD
Nedocromil—HSP90AA1—vagina—acquired immunodeficiency syndrome	0.00379	0.0137	CbGeAlD
Nedocromil—CYSLTR1—central nervous system—acquired immunodeficiency syndrome	0.00368	0.0133	CbGeAlD
Nedocromil—HSP90AA1—lung—acquired immunodeficiency syndrome	0.00358	0.0129	CbGeAlD
Nedocromil—HSP90AA1—nervous system—acquired immunodeficiency syndrome	0.00332	0.012	CbGeAlD
Nedocromil—HSP90AA1—central nervous system—acquired immunodeficiency syndrome	0.00319	0.0115	CbGeAlD
Nedocromil—CYSLTR1—brain—acquired immunodeficiency syndrome	0.00292	0.0106	CbGeAlD
Nedocromil—CYSLTR1—lymph node—acquired immunodeficiency syndrome	0.00282	0.0102	CbGeAlD
Nedocromil—HSP90AA1—brain—acquired immunodeficiency syndrome	0.00254	0.00917	CbGeAlD
Nedocromil—HSP90AA1—lymph node—acquired immunodeficiency syndrome	0.00245	0.00886	CbGeAlD
Nedocromil—FPR1—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.0016	0.00519	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.00158	0.00511	CbGpPWpGaD
Nedocromil—HSP90AA1—Binding and Uptake of Ligands by Scavenger Receptors—ALB—acquired immunodeficiency syndrome	0.00157	0.00508	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.00156	0.00505	CbGpPWpGaD
Nedocromil—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.00151	0.00491	CbGpPWpGaD
Nedocromil—FPR1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.0015	0.00486	CbGpPWpGaD
Nedocromil—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.00149	0.00484	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.00148	0.0048	CbGpPWpGaD
Nedocromil—HSP90AA1—EBV LMP1 signaling—TNF—acquired immunodeficiency syndrome	0.00147	0.00477	CbGpPWpGaD
Nedocromil—PTGDR—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.00145	0.00469	CbGpPWpGaD
Nedocromil—FPR1—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.00144	0.00468	CbGpPWpGaD
Nedocromil—HSP90AA1—Glucocorticoid receptor regulatory network—CSF2—acquired immunodeficiency syndrome	0.00138	0.00448	CbGpPWpGaD
Nedocromil—HSP90AA1—IL2 signaling events mediated by PI3K—IL2—acquired immunodeficiency syndrome	0.00138	0.00447	CbGpPWpGaD
Nedocromil—HSP90AA1—Glucocorticoid receptor regulatory network—IL4—acquired immunodeficiency syndrome	0.00136	0.00441	CbGpPWpGaD
Nedocromil—FPR1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.00136	0.0044	CbGpPWpGaD
Nedocromil—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.00135	0.00437	CbGpPWpGaD
Nedocromil—FPR1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.00134	0.00434	CbGpPWpGaD
Nedocromil—PTGDR—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.00131	0.00425	CbGpPWpGaD
Nedocromil—HSP90AA1—Aryl Hydrocarbon Receptor Pathway—IFNG—acquired immunodeficiency syndrome	0.0013	0.00423	CbGpPWpGaD
Nedocromil—PTGDR—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.00129	0.00419	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.00128	0.00413	CbGpPWpGaD
Nedocromil—FPR1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.00128	0.00413	CbGpPWpGaD
Nedocromil—FPR1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.00128	0.00413	CbGpPWpGaD
Nedocromil—FPR1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.00127	0.00413	CbGpPWpGaD
Nedocromil—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.00127	0.00411	CbGpPWpGaD
Nedocromil—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.00127	0.00411	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00125	0.00404	CbGpPWpGaD
Nedocromil—PTGDR—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.00123	0.00399	CbGpPWpGaD
Nedocromil—PTGDR—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.00123	0.00399	CbGpPWpGaD
Nedocromil—PTGDR—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.00123	0.00399	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00121	0.00394	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.0012	0.0039	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00117	0.0038	CbGpPWpGaD
Nedocromil—Visual impairment—Ritonavir—acquired immunodeficiency syndrome	0.00117	0.00287	CcSEcCtD
Nedocromil—Dysgeusia—Efavirenz—acquired immunodeficiency syndrome	0.00117	0.00287	CcSEcCtD
Nedocromil—Sinusitis—Lamivudine—acquired immunodeficiency syndrome	0.00116	0.00286	CcSEcCtD
Nedocromil—HSP90AA1—Aryl Hydrocarbon Receptor Pathway—IL2—acquired immunodeficiency syndrome	0.00116	0.00376	CbGpPWpGaD
Nedocromil—Body temperature increased—Didanosine—acquired immunodeficiency syndrome	0.00116	0.00285	CcSEcCtD
Nedocromil—Abdominal pain—Didanosine—acquired immunodeficiency syndrome	0.00116	0.00285	CcSEcCtD
Nedocromil—Pharyngitis—Saquinavir—acquired immunodeficiency syndrome	0.00116	0.00285	CcSEcCtD
Nedocromil—Chest pain—Zidovudine—acquired immunodeficiency syndrome	0.00115	0.00284	CcSEcCtD
Nedocromil—Asthenia—Amprenavir—acquired immunodeficiency syndrome	0.00115	0.00284	CcSEcCtD
Nedocromil—CYSLTR1—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.00115	0.00374	CbGpPWpGaD
Nedocromil—FPR1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.00115	0.00372	CbGpPWpGaD
Nedocromil—Dyspnoea—Nelfinavir—acquired immunodeficiency syndrome	0.00114	0.0028	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Nevirapine—acquired immunodeficiency syndrome	0.00114	0.0028	CcSEcCtD
Nedocromil—CYSLTR2—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.00114	0.00368	CbGpPWpGaD
Nedocromil—Fatigue—Nevirapine—acquired immunodeficiency syndrome	0.00114	0.0028	CcSEcCtD
Nedocromil—Pain—Nevirapine—acquired immunodeficiency syndrome	0.00113	0.00278	CcSEcCtD
Nedocromil—FPR1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00113	0.00365	CbGpPWpGaD
Nedocromil—Dyspepsia—Nelfinavir—acquired immunodeficiency syndrome	0.00112	0.00277	CcSEcCtD
Nedocromil—Visual impairment—Saquinavir—acquired immunodeficiency syndrome	0.00112	0.00277	CcSEcCtD
Nedocromil—Dyspepsia—Stavudine—acquired immunodeficiency syndrome	0.00112	0.00276	CcSEcCtD
Nedocromil—Dyspnoea—Abacavir—acquired immunodeficiency syndrome	0.00112	0.00275	CcSEcCtD
Nedocromil—Dysgeusia—Delavirdine—acquired immunodeficiency syndrome	0.00112	0.00275	CcSEcCtD
Nedocromil—Tremor—Efavirenz—acquired immunodeficiency syndrome	0.00112	0.00275	CcSEcCtD
Nedocromil—Rhinitis—Lamivudine—acquired immunodeficiency syndrome	0.00111	0.00274	CcSEcCtD
Nedocromil—PTGDR—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.00111	0.00359	CbGpPWpGaD
Nedocromil—Anaphylactic shock—Zidovudine—acquired immunodeficiency syndrome	0.00111	0.00272	CcSEcCtD
Nedocromil—Pharyngitis—Lamivudine—acquired immunodeficiency syndrome	0.0011	0.00272	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.0011	0.00271	CcSEcCtD
Nedocromil—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.0011	0.00271	CcSEcCtD
Nedocromil—Cough—Indinavir—acquired immunodeficiency syndrome	0.0011	0.00271	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.0011	0.00271	CcSEcCtD
Nedocromil—Fatigue—Stavudine—acquired immunodeficiency syndrome	0.0011	0.0027	CcSEcCtD
Nedocromil—CYSLTR1—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.00109	0.00354	CbGpPWpGaD
Nedocromil—Pain—Nelfinavir—acquired immunodeficiency syndrome	0.00109	0.00269	CcSEcCtD
Nedocromil—Pain—Stavudine—acquired immunodeficiency syndrome	0.00109	0.00268	CcSEcCtD
Nedocromil—PTGDR—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00109	0.00353	CbGpPWpGaD
Nedocromil—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.00108	0.00267	CcSEcCtD
Nedocromil—Fatigue—Abacavir—acquired immunodeficiency syndrome	0.00108	0.00266	CcSEcCtD
Nedocromil—CYSLTR1—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.00108	0.0035	CbGpPWpGaD
Nedocromil—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.00108	0.00266	CcSEcCtD
Nedocromil—Gastrointestinal pain—Nevirapine—acquired immunodeficiency syndrome	0.00108	0.00265	CcSEcCtD
Nedocromil—Chest pain—Indinavir—acquired immunodeficiency syndrome	0.00107	0.00264	CcSEcCtD
Nedocromil—Pain—Abacavir—acquired immunodeficiency syndrome	0.00107	0.00264	CcSEcCtD
Nedocromil—Tremor—Delavirdine—acquired immunodeficiency syndrome	0.00107	0.00263	CcSEcCtD
Nedocromil—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.00105	0.00259	CcSEcCtD
Nedocromil—Dry mouth—Indinavir—acquired immunodeficiency syndrome	0.00105	0.00258	CcSEcCtD
Nedocromil—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.00105	0.00258	CcSEcCtD
Nedocromil—Gastrointestinal pain—Nelfinavir—acquired immunodeficiency syndrome	0.00104	0.00257	CcSEcCtD
Nedocromil—Body temperature increased—Nevirapine—acquired immunodeficiency syndrome	0.00104	0.00257	CcSEcCtD
Nedocromil—Abdominal pain—Nevirapine—acquired immunodeficiency syndrome	0.00104	0.00257	CcSEcCtD
Nedocromil—Gastrointestinal pain—Stavudine—acquired immunodeficiency syndrome	0.00104	0.00256	CcSEcCtD
Nedocromil—Cough—Efavirenz—acquired immunodeficiency syndrome	0.00104	0.00256	CcSEcCtD
Nedocromil—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.00103	0.00335	CbGpPWpGaD
Nedocromil—Dysgeusia—Ritonavir—acquired immunodeficiency syndrome	0.00103	0.00254	CcSEcCtD
Nedocromil—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.00103	0.00253	CcSEcCtD
Nedocromil—CYSLTR2—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.00103	0.00333	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.00103	0.00333	CbGpPWpGaD
Nedocromil—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	0.00103	0.00252	CcSEcCtD
Nedocromil—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.00102	0.00252	CcSEcCtD
Nedocromil—Leukopenia—Delavirdine—acquired immunodeficiency syndrome	0.00102	0.00251	CcSEcCtD
Nedocromil—CYSLTR2—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.00102	0.00329	CbGpPWpGaD
Nedocromil—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.00101	0.0025	CcSEcCtD
Nedocromil—Chest pain—Efavirenz—acquired immunodeficiency syndrome	0.00101	0.0025	CcSEcCtD
Nedocromil—Rash—Amprenavir—acquired immunodeficiency syndrome	0.00101	0.0025	CcSEcCtD
Nedocromil—HSP90AA1—Axon guidance—ACTG1—acquired immunodeficiency syndrome	0.00101	0.00329	CbGpPWpGaD
Nedocromil—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.00101	0.00249	CcSEcCtD
Nedocromil—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.00101	0.00249	CcSEcCtD
Nedocromil—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.00101	0.00249	CcSEcCtD
Nedocromil—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.00101	0.00249	CcSEcCtD
Nedocromil—Headache—Amprenavir—acquired immunodeficiency syndrome	0.00101	0.00248	CcSEcCtD
Nedocromil—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.00101	0.00248	CcSEcCtD
Nedocromil—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.00101	0.00248	CcSEcCtD
Nedocromil—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.001	0.00247	CcSEcCtD
Nedocromil—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.000996	0.00245	CcSEcCtD
Nedocromil—Cough—Delavirdine—acquired immunodeficiency syndrome	0.000994	0.00245	CcSEcCtD
Nedocromil—Dysgeusia—Saquinavir—acquired immunodeficiency syndrome	0.000993	0.00245	CcSEcCtD
Nedocromil—Dry mouth—Efavirenz—acquired immunodeficiency syndrome	0.000992	0.00244	CcSEcCtD
Nedocromil—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.000991	0.00244	CcSEcCtD
Nedocromil—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.000991	0.00244	CcSEcCtD
Nedocromil—Tremor—Ritonavir—acquired immunodeficiency syndrome	0.000987	0.00243	CcSEcCtD
Nedocromil—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.000986	0.00243	CcSEcCtD
Nedocromil—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.000974	0.0024	CcSEcCtD
Nedocromil—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000971	0.00239	CcSEcCtD
Nedocromil—FPR1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.00097	0.00314	CbGpPWpGaD
Nedocromil—Chest pain—Delavirdine—acquired immunodeficiency syndrome	0.00097	0.00239	CcSEcCtD
Nedocromil—CYSLTR2—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000966	0.00313	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000966	0.00313	CbGpPWpGaD
Nedocromil—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000965	0.00313	CbGpPWpGaD
Nedocromil—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000955	0.00235	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000955	0.00235	CcSEcCtD
Nedocromil—HSP90AA1—Regulation of Telomerase—IFNG—acquired immunodeficiency syndrome	0.000954	0.00309	CbGpPWpGaD
Nedocromil—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000954	0.00235	CcSEcCtD
Nedocromil—Tremor—Saquinavir—acquired immunodeficiency syndrome	0.00095	0.00234	CcSEcCtD
Nedocromil—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.000949	0.00234	CcSEcCtD
Nedocromil—Dysgeusia—Lamivudine—acquired immunodeficiency syndrome	0.000947	0.00233	CcSEcCtD
Nedocromil—Pain—Zidovudine—acquired immunodeficiency syndrome	0.000946	0.00233	CcSEcCtD
Nedocromil—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000946	0.00233	CcSEcCtD
Nedocromil—CYSLTR2—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000944	0.00306	CbGpPWpGaD
Nedocromil—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.000943	0.00232	CcSEcCtD
Nedocromil—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.00094	0.00232	CcSEcCtD
Nedocromil—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000938	0.00231	CcSEcCtD
Nedocromil—PTGDR—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000937	0.00304	CbGpPWpGaD
Nedocromil—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000936	0.00303	CbGpPWpGaD
Nedocromil—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000932	0.0023	CcSEcCtD
Nedocromil—Rash—Didanosine—acquired immunodeficiency syndrome	0.000924	0.00228	CcSEcCtD
Nedocromil—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000924	0.00227	CcSEcCtD
Nedocromil—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000923	0.00227	CcSEcCtD
Nedocromil—CYSLTR2—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000921	0.00298	CbGpPWpGaD
Nedocromil—Cough—Ritonavir—acquired immunodeficiency syndrome	0.000919	0.00226	CcSEcCtD
Nedocromil—Headache—Didanosine—acquired immunodeficiency syndrome	0.000918	0.00226	CcSEcCtD
Nedocromil—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000917	0.00226	CcSEcCtD
Nedocromil—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000916	0.00226	CcSEcCtD
Nedocromil—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000913	0.00225	CcSEcCtD
Nedocromil—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000908	0.00224	CcSEcCtD
Nedocromil—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000906	0.00223	CcSEcCtD
Nedocromil—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000906	0.00223	CcSEcCtD
Nedocromil—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000905	0.00223	CcSEcCtD
Nedocromil—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000902	0.00222	CcSEcCtD
Nedocromil—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.0009	0.00222	CcSEcCtD
Nedocromil—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000897	0.00221	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000888	0.00219	CcSEcCtD
Nedocromil—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000887	0.00218	CcSEcCtD
Nedocromil—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000885	0.00218	CcSEcCtD
Nedocromil—Pain—Indinavir—acquired immunodeficiency syndrome	0.00088	0.00217	CcSEcCtD
Nedocromil—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.00088	0.00285	CbGpPWpGaD
Nedocromil—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.00088	0.00285	CbGpPWpGaD
Nedocromil—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000879	0.00216	CcSEcCtD
Nedocromil—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000877	0.00216	CcSEcCtD
Nedocromil—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000874	0.00215	CcSEcCtD
Nedocromil—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000874	0.00215	CcSEcCtD
Nedocromil—FPR1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000874	0.00283	CbGpPWpGaD
Nedocromil—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000873	0.00215	CcSEcCtD
Nedocromil—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000871	0.00214	CcSEcCtD
Nedocromil—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000871	0.00214	CcSEcCtD
Nedocromil—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.00087	0.00282	CbGpPWpGaD
Nedocromil—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000867	0.00213	CcSEcCtD
Nedocromil—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000866	0.00213	CcSEcCtD
Nedocromil—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000863	0.00213	CcSEcCtD
Nedocromil—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000858	0.00211	CcSEcCtD
Nedocromil—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000856	0.00211	CcSEcCtD
Nedocromil—CYSLTR2—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000854	0.00277	CbGpPWpGaD
Nedocromil—HSP90AA1—Regulation of Telomerase—IL2—acquired immunodeficiency syndrome	0.000848	0.00275	CbGpPWpGaD
Nedocromil—HSP90AA1—Aryl Hydrocarbon Receptor Pathway—TNF—acquired immunodeficiency syndrome	0.000844	0.00274	CbGpPWpGaD
Nedocromil—HSP90AA1—Aryl Hydrocarbon Receptor—TNF—acquired immunodeficiency syndrome	0.000844	0.00274	CbGpPWpGaD
Nedocromil—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000844	0.00208	CcSEcCtD
Nedocromil—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000844	0.00208	CcSEcCtD
Nedocromil—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000844	0.00208	CcSEcCtD
Nedocromil—PTGDR—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000844	0.00274	CbGpPWpGaD
Nedocromil—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000842	0.00207	CcSEcCtD
Nedocromil—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000841	0.00207	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000839	0.00207	CcSEcCtD
Nedocromil—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000838	0.00206	CcSEcCtD
Nedocromil—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000838	0.00206	CcSEcCtD
Nedocromil—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000831	0.00205	CcSEcCtD
Nedocromil—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000831	0.00205	CcSEcCtD
Nedocromil—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.00083	0.00204	CcSEcCtD
Nedocromil—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000829	0.00204	CcSEcCtD
Nedocromil—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000829	0.00204	CcSEcCtD
Nedocromil—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000826	0.00203	CcSEcCtD
Nedocromil—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000824	0.00203	CcSEcCtD
Nedocromil—HSP90AA1—Glucocorticoid receptor regulatory network—IFNG—acquired immunodeficiency syndrome	0.000822	0.00266	CbGpPWpGaD
Nedocromil—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000819	0.00202	CcSEcCtD
Nedocromil—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000817	0.00201	CcSEcCtD
Nedocromil—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000813	0.002	CcSEcCtD
Nedocromil—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000813	0.002	CcSEcCtD
Nedocromil—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000812	0.002	CcSEcCtD
Nedocromil—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000809	0.00199	CcSEcCtD
Nedocromil—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000806	0.00198	CcSEcCtD
Nedocromil—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000805	0.00198	CcSEcCtD
Nedocromil—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000804	0.00198	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000803	0.00198	CcSEcCtD
Nedocromil—Rash—Stavudine—acquired immunodeficiency syndrome	0.000802	0.00198	CcSEcCtD
Nedocromil—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000802	0.00197	CcSEcCtD
Nedocromil—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000802	0.00197	CcSEcCtD
Nedocromil—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.0008	0.00197	CcSEcCtD
Nedocromil—Headache—Stavudine—acquired immunodeficiency syndrome	0.000797	0.00196	CcSEcCtD
Nedocromil—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000797	0.00196	CcSEcCtD
Nedocromil—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000795	0.00196	CcSEcCtD
Nedocromil—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000795	0.00196	CcSEcCtD
Nedocromil—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000794	0.00195	CcSEcCtD
Nedocromil—Rash—Abacavir—acquired immunodeficiency syndrome	0.00079	0.00195	CcSEcCtD
Nedocromil—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.00079	0.00195	CcSEcCtD
Nedocromil—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.00079	0.00194	CcSEcCtD
Nedocromil—CYSLTR1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000788	0.00255	CbGpPWpGaD
Nedocromil—Headache—Abacavir—acquired immunodeficiency syndrome	0.000785	0.00193	CcSEcCtD
Nedocromil—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000783	0.00193	CcSEcCtD
Nedocromil—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000772	0.0019	CcSEcCtD
Nedocromil—FPR1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.00077	0.00249	CbGpPWpGaD
Nedocromil—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000768	0.00189	CcSEcCtD
Nedocromil—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000768	0.00189	CcSEcCtD
Nedocromil—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000767	0.00189	CcSEcCtD
Nedocromil—FPR1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000766	0.00248	CbGpPWpGaD
Nedocromil—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.00076	0.00187	CcSEcCtD
Nedocromil—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000758	0.00187	CcSEcCtD
Nedocromil—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000758	0.00187	CcSEcCtD
Nedocromil—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000757	0.00186	CcSEcCtD
Nedocromil—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000757	0.00186	CcSEcCtD
Nedocromil—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000756	0.00186	CcSEcCtD
Nedocromil—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000745	0.00183	CcSEcCtD
Nedocromil—PTGDR—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000743	0.00241	CbGpPWpGaD
Nedocromil—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000742	0.00183	CcSEcCtD
Nedocromil—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000741	0.00183	CcSEcCtD
Nedocromil—PTGDR—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.00074	0.0024	CbGpPWpGaD
Nedocromil—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000739	0.00182	CcSEcCtD
Nedocromil—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000738	0.00182	CcSEcCtD
Nedocromil—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000738	0.00182	CcSEcCtD
Nedocromil—FPR1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000736	0.00239	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000736	0.00239	CbGpPWpGaD
Nedocromil—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000735	0.00181	CcSEcCtD
Nedocromil—CYSLTR2—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000735	0.00238	CbGpPWpGaD
Nedocromil—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000735	0.00181	CcSEcCtD
Nedocromil—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000735	0.00181	CcSEcCtD
Nedocromil—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000731	0.0018	CcSEcCtD
Nedocromil—HSP90AA1—Glucocorticoid receptor regulatory network—IL2—acquired immunodeficiency syndrome	0.00073	0.00237	CbGpPWpGaD
Nedocromil—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000729	0.00179	CcSEcCtD
Nedocromil—HSP90AA1—Developmental Biology—ACTG1—acquired immunodeficiency syndrome	0.000723	0.00234	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000721	0.00234	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000721	0.00234	CbGpPWpGaD
Nedocromil—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000716	0.00176	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000715	0.00176	CcSEcCtD
Nedocromil—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000714	0.00176	CcSEcCtD
Nedocromil—CYSLTR1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000712	0.00231	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000711	0.0023	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000711	0.0023	CbGpPWpGaD
Nedocromil—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000708	0.00174	CcSEcCtD
Nedocromil—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000704	0.00173	CcSEcCtD
Nedocromil—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000704	0.00173	CcSEcCtD
Nedocromil—CYSLTR1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000704	0.00228	CbGpPWpGaD
Nedocromil—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000703	0.00173	CcSEcCtD
Nedocromil—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000703	0.00173	CcSEcCtD
Nedocromil—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000697	0.00172	CcSEcCtD
Nedocromil—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000697	0.00172	CcSEcCtD
Nedocromil—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000697	0.00172	CcSEcCtD
Nedocromil—FPR1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000696	0.00226	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000696	0.00226	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000696	0.00226	CbGpPWpGaD
Nedocromil—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000695	0.00171	CcSEcCtD
Nedocromil—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000693	0.00171	CcSEcCtD
Nedocromil—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000685	0.00169	CcSEcCtD
Nedocromil—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000683	0.00168	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000682	0.00168	CcSEcCtD
Nedocromil—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000681	0.00168	CcSEcCtD
Nedocromil—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.00068	0.00168	CcSEcCtD
Nedocromil—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.00068	0.00167	CcSEcCtD
Nedocromil—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.00068	0.00167	CcSEcCtD
Nedocromil—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000677	0.00167	CcSEcCtD
Nedocromil—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000675	0.00166	CcSEcCtD
Nedocromil—PTGDR—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000672	0.00218	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.00067	0.00217	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.00067	0.00217	CbGpPWpGaD
Nedocromil—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000669	0.00217	CbGpPWpGaD
Nedocromil—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000667	0.00164	CcSEcCtD
Nedocromil—HSP90AA1—Corticotropin-releasing hormone—IL2—acquired immunodeficiency syndrome	0.000666	0.00216	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000666	0.00216	CbGpPWpGaD
Nedocromil—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000665	0.00164	CcSEcCtD
Nedocromil—CYSLTR2—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000662	0.00215	CbGpPWpGaD
Nedocromil—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000658	0.00162	CcSEcCtD
Nedocromil—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000657	0.00162	CcSEcCtD
Nedocromil—CYSLTR1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000654	0.00212	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000654	0.00212	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000654	0.00212	CbGpPWpGaD
Nedocromil—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000654	0.00161	CcSEcCtD
Nedocromil—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000654	0.00161	CcSEcCtD
Nedocromil—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000654	0.00161	CcSEcCtD
Nedocromil—Rash—Indinavir—acquired immunodeficiency syndrome	0.000649	0.0016	CcSEcCtD
Nedocromil—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000648	0.0016	CcSEcCtD
Nedocromil—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000646	0.00159	CcSEcCtD
Nedocromil—Headache—Indinavir—acquired immunodeficiency syndrome	0.000644	0.00159	CcSEcCtD
Nedocromil—PTGDR—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000643	0.00208	CbGpPWpGaD
Nedocromil—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000643	0.00158	CcSEcCtD
Nedocromil—HSP90AA1—Innate Immune System—ACTG1—acquired immunodeficiency syndrome	0.000639	0.00207	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000638	0.00207	CbGpPWpGaD
Nedocromil—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000636	0.00157	CcSEcCtD
Nedocromil—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000634	0.00156	CcSEcCtD
Nedocromil—PTGDR—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000632	0.00205	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000632	0.00205	CbGpPWpGaD
Nedocromil—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000627	0.00154	CcSEcCtD
Nedocromil—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000624	0.00154	CcSEcCtD
Nedocromil—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000624	0.00154	CcSEcCtD
Nedocromil—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000618	0.00152	CcSEcCtD
Nedocromil—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000617	0.00152	CcSEcCtD
Nedocromil—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000615	0.00151	CcSEcCtD
Nedocromil—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000613	0.00151	CcSEcCtD
Nedocromil—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000612	0.00151	CcSEcCtD
Nedocromil—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000611	0.0015	CcSEcCtD
Nedocromil—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.00061	0.0015	CcSEcCtD
Nedocromil—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000609	0.0015	CcSEcCtD
Nedocromil—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000603	0.00195	CbGpPWpGaD
Nedocromil—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000594	0.00146	CcSEcCtD
Nedocromil—CYSLTR1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000592	0.00192	CbGpPWpGaD
Nedocromil—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000591	0.00146	CcSEcCtD
Nedocromil—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000588	0.00145	CcSEcCtD
Nedocromil—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000586	0.00144	CcSEcCtD
Nedocromil—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000586	0.00144	CcSEcCtD
Nedocromil—CYSLTR2—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000583	0.00189	CbGpPWpGaD
Nedocromil—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000583	0.00143	CcSEcCtD
Nedocromil—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000582	0.00143	CcSEcCtD
Nedocromil—CYSLTR2—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000581	0.00188	CbGpPWpGaD
Nedocromil—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000577	0.00142	CcSEcCtD
Nedocromil—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000569	0.0014	CcSEcCtD
Nedocromil—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000567	0.0014	CcSEcCtD
Nedocromil—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000566	0.00139	CcSEcCtD
Nedocromil—CYSLTR2—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000558	0.00181	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000558	0.00181	CbGpPWpGaD
Nedocromil—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000552	0.00136	CcSEcCtD
Nedocromil—FPR1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000548	0.00178	CbGpPWpGaD
Nedocromil—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000547	0.00135	CcSEcCtD
Nedocromil—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000547	0.00135	CcSEcCtD
Nedocromil—CYSLTR2—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000546	0.00177	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000546	0.00177	CbGpPWpGaD
Nedocromil—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000542	0.00134	CcSEcCtD
Nedocromil—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000542	0.00133	CcSEcCtD
Nedocromil—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.00054	0.00133	CcSEcCtD
Nedocromil—FPR1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.00054	0.00175	CbGpPWpGaD
Nedocromil—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000539	0.00133	CcSEcCtD
Nedocromil—PTGDR—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000529	0.00172	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000527	0.00171	CbGpPWpGaD
Nedocromil—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000526	0.0013	CcSEcCtD
Nedocromil—HSP90AA1—Innate Immune System—MBL2—acquired immunodeficiency syndrome	0.000525	0.0017	CbGpPWpGaD
Nedocromil—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000522	0.00129	CcSEcCtD
Nedocromil—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000522	0.00129	CcSEcCtD
Nedocromil—PTGDR—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000522	0.00169	CbGpPWpGaD
Nedocromil—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000521	0.00128	CcSEcCtD
Nedocromil—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000519	0.00128	CcSEcCtD
Nedocromil—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000511	0.00126	CcSEcCtD
Nedocromil—CYSLTR1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.00051	0.00165	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000504	0.00163	CbGpPWpGaD
Nedocromil—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000502	0.00124	CcSEcCtD
Nedocromil—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000498	0.00123	CcSEcCtD
Nedocromil—FPR1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000498	0.00161	CbGpPWpGaD
Nedocromil—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000497	0.00123	CcSEcCtD
Nedocromil—CYSLTR2—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000496	0.00161	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000496	0.00161	CbGpPWpGaD
Nedocromil—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000495	0.00122	CcSEcCtD
Nedocromil—FPR1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000494	0.0016	CbGpPWpGaD
Nedocromil—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000492	0.00121	CcSEcCtD
Nedocromil—FPR1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.00049	0.00159	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—TAT—acquired immunodeficiency syndrome	0.000488	0.00158	CbGpPWpGaD
Nedocromil—HSP90AA1—TNF alpha Signaling Pathway—TNF—acquired immunodeficiency syndrome	0.000485	0.00157	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000481	0.00156	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000477	0.00155	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000474	0.00154	CbGpPWpGaD
Nedocromil—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000469	0.00116	CcSEcCtD
Nedocromil—HSP90AA1—Disease—APOBEC3G—acquired immunodeficiency syndrome	0.000466	0.00151	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000459	0.00149	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000458	0.00148	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000455	0.00147	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000449	0.00145	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000439	0.00142	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000433	0.0014	CbGpPWpGaD
Nedocromil—HSP90AA1—Glucocorticoid receptor regulatory network—IL6—acquired immunodeficiency syndrome	0.000429	0.00139	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000415	0.00135	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000415	0.00135	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—CCR2—acquired immunodeficiency syndrome	0.000412	0.00133	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000411	0.00133	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000409	0.00133	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000404	0.00131	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000403	0.0013	CbGpPWpGaD
Nedocromil—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.000399	0.00129	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000397	0.00129	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—CCNT1—acquired immunodeficiency syndrome	0.000396	0.00128	CbGpPWpGaD
Nedocromil—HSP90AA1—TNF alpha Signaling Pathway—IL6—acquired immunodeficiency syndrome	0.000391	0.00127	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000387	0.00125	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000387	0.00125	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000387	0.00125	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000387	0.00125	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000379	0.00123	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000379	0.00123	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000377	0.00122	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000374	0.00121	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000373	0.00121	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000373	0.00121	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—ACTG1—acquired immunodeficiency syndrome	0.000372	0.00121	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000372	0.0012	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—IFNA1—acquired immunodeficiency syndrome	0.000371	0.0012	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000366	0.00119	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.00035	0.00113	CbGpPWpGaD
Nedocromil—HSP90AA1—VEGFA-VEGFR2 Pathway—IL6—acquired immunodeficiency syndrome	0.000347	0.00112	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000345	0.00112	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000344	0.00111	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000344	0.00111	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.00034	0.0011	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by VEGF—IL6—acquired immunodeficiency syndrome	0.000327	0.00106	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000312	0.00101	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—MBL2—acquired immunodeficiency syndrome	0.000306	0.000991	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000294	0.000953	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000293	0.00095	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000293	0.00095	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.00029	0.000939	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000288	0.000933	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000285	0.000925	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000284	0.000921	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000284	0.000919	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.00028	0.000907	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—HLA-B—acquired immunodeficiency syndrome	0.000279	0.000904	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000277	0.000899	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000277	0.000899	CbGpPWpGaD
Nedocromil—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.000277	0.000896	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000276	0.000893	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000265	0.000859	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000262	0.000848	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000259	0.000841	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000259	0.00084	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000258	0.000835	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000256	0.000829	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000251	0.000813	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.00025	0.000811	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by ERBB2—IL6—acquired immunodeficiency syndrome	0.000248	0.000803	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CCR2—acquired immunodeficiency syndrome	0.00024	0.000777	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000239	0.000774	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000236	0.000764	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—IL6—acquired immunodeficiency syndrome	0.000228	0.000738	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000223	0.000722	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.00022	0.000712	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000216	0.000701	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000216	0.0007	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IFNA1—acquired immunodeficiency syndrome	0.000216	0.0007	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CD79A—acquired immunodeficiency syndrome	0.00021	0.000679	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—CXCR4—acquired immunodeficiency syndrome	0.000208	0.000675	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000203	0.000658	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000203	0.000658	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000201	0.000651	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000196	0.000637	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000171	0.000556	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CD40LG—acquired immunodeficiency syndrome	0.000171	0.000554	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CSF2—acquired immunodeficiency syndrome	0.000169	0.000548	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CD8A—acquired immunodeficiency syndrome	0.000169	0.000548	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular responses to stress—IL6—acquired immunodeficiency syndrome	0.000168	0.000546	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—CD4—acquired immunodeficiency syndrome	0.000167	0.00054	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—HLA-B—acquired immunodeficiency syndrome	0.000163	0.000527	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000155	0.000502	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000154	0.000501	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000153	0.000496	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000152	0.000494	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000152	0.000493	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.00015	0.000486	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000148	0.000479	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000147	0.000477	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000146	0.000472	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000146	0.000472	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—IL6—acquired immunodeficiency syndrome	0.000143	0.000463	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—CCR5—acquired immunodeficiency syndrome	0.000143	0.000462	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000139	0.000451	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000136	0.000441	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—TNF—acquired immunodeficiency syndrome	0.000126	0.00041	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000116	0.000376	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000115	0.000374	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000111	0.000359	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000109	0.000354	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—IL6—acquired immunodeficiency syndrome	0.000102	0.000331	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IFNG—acquired immunodeficiency syndrome	0.0001	0.000326	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	9.99e-05	0.000324	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CD4—acquired immunodeficiency syndrome	9.7e-05	0.000314	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—IL6—acquired immunodeficiency syndrome	9.01e-05	0.000292	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	9e-05	0.000292	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—CD4—acquired immunodeficiency syndrome	8.96e-05	0.00029	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IL2—acquired immunodeficiency syndrome	8.93e-05	0.000289	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—IL6—acquired immunodeficiency syndrome	8.69e-05	0.000282	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—ALB—acquired immunodeficiency syndrome	8.51e-05	0.000276	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	8.04e-05	0.000261	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	8e-05	0.000259	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.82e-05	0.000221	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.77e-05	0.000187	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IL6—acquired immunodeficiency syndrome	5.25e-05	0.00017	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—IL6—acquired immunodeficiency syndrome	4.84e-05	0.000157	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.73e-05	0.000153	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.39e-05	0.00011	CbGpPWpGaD
